• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Healthcare·TKUN.TA
Share

Tikun Olam-Cannbit Pharmaceuticals Ltd Stocks

ILA 1390Last Updated 12.06.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

ILA 41033.09686

ILA 1390
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Nof Hagalil, Israel, Tikun Olam-Cannbit Pharmaceuticals Ltd operates across the full spectrum of the medical cannabis industry. Its comprehensive activities encompass researching and developing new therapeutic cannabis offerings, cultivating the plants, manufacturing the final products, and distributing them. Additionally, the company provides vital training and patient support services.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is undervalued on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.06.2026 07:00

An analyst called the sell-off following SpaceX's IPO excessive. Which stocks did he recommend?

16.06.2026 04:40

SpaceX shares surged 20% on the second day of trading. What investors should watch next

16.06.2026 03:34

Nvidia to raise $25 billion in its first bond offering in five years — Reuters

16.06.2026 01:21

Dow hits record high and Nasdaq posts its best day since March: Market rallies on US-Iran deal

16.06.2026 00:25

TD Cowen expects Micron's stock to rise by more than 50%. What new growth driver has the bank identified?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026